Evidence map›Paper›PMID 38893489›Full record

ArticleMolecules (Basel, Switzerland)2024

Enrichment of Trypsin Inhibitor from Soybean Whey Wastewater Using Different Precipitating Agents and Analysis of Their Properties.

Yongsheng Zhou, Siyun Zhou, Cuiwen Lu, Yihao Zhang, Haiyan Zhao

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yongsheng ZhouCollege of Food and Biochemical Engineering, Guangxi Science & Technology Normal University, Laibin 546199, China.
Siyun ZhouCollege of Food and Biochemical Engineering, Guangxi Science & Technology Normal University, Laibin 546199, China.
Cuiwen LuCollege of Food and Biochemical Engineering, Guangxi Science & Technology Normal University, Laibin 546199, China.
Yihao ZhangCollege of Food and Biochemical Engineering, Guangxi Science & Technology Normal University, Laibin 546199, China.
Haiyan ZhaoCollege of Food and Biochemical Engineering, Guangxi Science & Technology Normal University, Laibin 546199, China.

Funding

the Basic Ability Enhancement Program for Young and Middle-aged Teachers in Guangxi Colleges and Universities 2024KY0864
6 · The paper itself

Abstract

Recovering valuable active substances from the by-products of agricultural processing is a crucial concern for scientific researchers. This paper focuses on the enrichment of soybean trypsin inhibitor (STI) from soybean whey wastewater using either ammonium sulfate salting or ethanol precipitation, and discusses their physicochemical properties. The results show that at a 60% ethanol content, the yield of STI was 3.983 mg/mL, whereas the yield was 3.833 mg/mL at 60% ammonium sulfate saturation. The inhibitory activity of STI obtained by ammonium sulfate salting out (A-STI) was higher than that obtained by ethanol precipitation (E-STI). A-STI exhibited better solubility than E-STI at specific temperatures and pH levels, as confirmed by turbidity and surface hydrophobicity measurements. Thermal characterization revealed that both A-STI and E-STI showed thermal transition temperatures above 90 °C. Scanning electron microscopy demonstrated that A-STI had a smooth surface with fewer pores, while E-STI had a rough surface with more pores. In conclusion, there was no significant difference in the yield of A-STI and E-STI (

Indexed as

Glycine maxTrypsin InhibitorsWastewaterWheyAmmonium SulfateChemical PrecipitationHydrogen-Ion ConcentrationHydrophobic and Hydrophilic InteractionsSolubilityTemperatureAmmonium SulfateTrypsin InhibitorsWastewaterethanol precipitationsoybean wheytrypsin inhibitor

Identifiers

PMID38893489
PMCPMC11173672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.